Carolyn Ross Mullen

age ~64

from Libertyville, IL

Get Report

Also known as:

Connected to:

Carolyn Mullen Phones & Addresses

Name / Title

Company / Classification

Phones & Addresses

Carolyn S. Mullen

LOCK 1000, LLC

Carolyn S Mullen

MOVIN-ON-UP, LLC

Carolyn Mullen

CHALLENGE PROPERTIES, LLC

Polynucleotides For The Detection And Quantification Of Hepatitis B Virus Nucleic Acids
view source
US Patent:

7015317, Mar 21, 2006
Filed:

May 2, 2002
Appl. No.:

10/138184
Inventors:

Carolyn Mullen - Libertyville IL, US
James Rhoads - Mundelein IL, US
Assignee:

Abbott Laboratories - Downers Grove IL
International Classification:

C07H 21/00
US Classification:

536 243, 530300, 900 10, 900220, 900223, 435 5, 435 6, 435 4, 435 29, 435 34, 435 39, 536 2433
Abstract:

The present invention provides polynucleotides that can specifically hybridise to Hepatitis B virus (HBV) nucleic acids from all genotypes. These polynucleotides can be used in genotype-independent detection and quantitation of HBV nucleic acids. For example, the polynucleotides can be used as primers and/or probes in amplification-based assays for either end-point detection or real-time monitoring of HBV nucleic acids in a test sample. The polynucleotides can additionally be provided as part of a kit for the detection and quantitation of HBV nucleic acids.

Fluorescent Enzyme Substrates
view source
US Patent:

59985933, Dec 7, 1999
Filed:

Mar 10, 1998
Appl. No.:

9/041192
Inventors:

Jeffrey B. Huff - Park Ridge IL
Barbara T. Merchant - Wilmette IL
Carolyn R. Mullen - Libertyville IL
Seshagiri R. Tata Venkata - Chicago IL
Assignee:

Abbott Laboratories - Abbott Park IL
International Classification:

C07H 1704
C07D31102
US Classification:

536 41
Abstract:

Fluorescent enzyme substrates are provided. The substrates are derivatives of coumarin having an enzyme cleavable group at position 7 and a hydrophilic amide group at position 4. The compounds are highly water soluble, stable at ambient and reduced temperatures and fluoresce upon cleavage by an enzyme.

Nucleic Acid Primers And Probes For Detecting Mycoplasma Pneumoniae
view source
US Patent:

58174630, Oct 6, 1998
Filed:

Jun 28, 1996
Appl. No.:

8/671892
Inventors:

Carolyn R. Mullen - Libertyville IL
Joann C. Sustachek - Racine WI
Assignee:

Abbott Laboratories - Abbott Park IL
International Classification:

C07H 2104
C12Q 168
C12P 1934
US Classification:

435 6
Abstract:

Nucleic acid sequences that are useful for detecting Mycoplasma pneumoniae are herein provided. These sequences can be used in hybridization assays or amplification based assays designed to detect the presence of Mycoplasma pneumoniae in a test sample. Additionally, the sequences can be provided as part of a kit.

Egfr Assay
view source
US Patent:

20200172983, Jun 4, 2020
Filed:

Jan 2, 2020
Appl. No.:

16/732727
Inventors:

- DES PLAINES IL, US
Kevin S. Nelson - Des Plaines IL, US
Shihai Huang - Des Plaines IL, US
Rupinder Kular - Des Plaines IL, US
Carolyn Mullen - Des Plaines IL, US
James Rhoads - Des Plaines IL, US
International Classification:

C12Q 1/6886
Abstract:

Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.

Egfr Assay
view source
US Patent:

20160376665, Dec 29, 2016
Filed:

Jun 23, 2016
Appl. No.:

15/191122
Inventors:

- Des Plaines IL, US
Kevin S. Nelson - Des Plaines IL, US
Shihai Huang - Des Plaines IL, US
Rupinder Kular - Des Plaines IL, US
Carolyn Mullen - Des Plaines IL, US
James Rhoads - Des Plaines IL, US
International Classification:

C12Q 1/68
Abstract:

Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.